Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5705630 | Ophthalmology | 2016 | 7 Pages |
Abstract
Introduction of anti-VEGF agents in 2006 for treating exudative AMD has not posed a threat of increased risk of AMI, stroke, or all-cause mortality.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Arseniy P. PhD, Paul MD, Frank A. PhD,